-
Something wrong with this record ?
Use of psychedelics in the Czech Republic: results of recent population surveys
P. Chomynová, R. Kočárová, F. Kňažek, M. Plevková, B. Bláhová, K. Valeš, V. Mravčík
Language English Country Czech Republic
Document type Journal Article
Digital library NLK
Source
NLK
Free Medical Journals
from 2004
ProQuest Central
from 2009-03-01 to 6 months ago
Medline Complete (EBSCOhost)
from 2006-03-01 to 6 months ago
Nursing & Allied Health Database (ProQuest)
from 2009-03-01 to 6 months ago
Health & Medicine (ProQuest)
from 2009-03-01 to 6 months ago
Public Health Database (ProQuest)
from 2009-03-01 to 6 months ago
ROAD: Directory of Open Access Scholarly Resources
from 1993
PubMed
36239361
DOI
10.21101/cejph.a7079
Knihovny.cz E-resources
- MeSH
- Cannabis * MeSH
- Adult MeSH
- Hallucinogens * therapeutic use MeSH
- Ketamine * MeSH
- Humans MeSH
- Lysergic Acid Diethylamide MeSH
- Substance-Related Disorders * epidemiology MeSH
- Cross-Sectional Studies MeSH
- Psilocybin MeSH
- Illicit Drugs * MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
OBJECTIVES: Different psychoactive substances are widely used in today's society. So far limited data are available on the use of psychedelics in the general population. The main aim of this study is to estimate the numbers of users of substances with psychedelic properties (classical psychedelics, cannabis, ecstasy, and ketamine) in the Czech Republic. METHODS: Data from two samples enrolled in representative cross-sectional questionnaire surveys in the Czech adult population in 2016 (n = 2,785) and 2018 (n = 1,665) were analysed. Prevalence rates were extrapolated to estimate numbers of current, i.e., last-year, users of psychedelics, and their socio-demographic profiles were compared with non-users and users of cannabis. RESULTS: An estimated 5-6% of the Czech adult population (350-430 thousand people) used classical psychedelics (LSD, psilocybin mushrooms, ayahuasca) in their lifetime, increasing up to 28-30% when cannabis is included (1.9-2.1 million users). Current use of classical psychedelics reached 0.7-1.9% (50-130 thousand people), and 9-11% (590-750 thousand users) when cannabis was included. Users of psychedelics were more often males, of younger age and single. CONCLUSIONS: No significant socio-demographic differences were found between users of classical psychedelics and recreational cannabis users, however, differences were significant when compared to non-users and users of other illicit drugs. Findings should further serve to inform drug policy and social and healthcare systems in respect to the use of psychedelics.
Beyond Psychedelics Prague Czech Republic
Faculty of Arts Charles University Prague Czech Republic
Faculty of Pharmacy Masaryk University Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22026969
- 003
- CZ-PrNML
- 005
- 20230314101943.0
- 007
- ta
- 008
- 221108s2022 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.21101/cejph.a7079 $2 doi
- 035 __
- $a (PubMed)36239361
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Chomynová, Pavla $u National Institute of Mental Health, Klecany, Czech Republic $u Czech National Monitoring Centre for Drugs and Addiction, Office of the Government of the Czech Republic, Prague, Czech Republic $u Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0118119
- 245 10
- $a Use of psychedelics in the Czech Republic: results of recent population surveys / $c P. Chomynová, R. Kočárová, F. Kňažek, M. Plevková, B. Bláhová, K. Valeš, V. Mravčík
- 520 9_
- $a OBJECTIVES: Different psychoactive substances are widely used in today's society. So far limited data are available on the use of psychedelics in the general population. The main aim of this study is to estimate the numbers of users of substances with psychedelic properties (classical psychedelics, cannabis, ecstasy, and ketamine) in the Czech Republic. METHODS: Data from two samples enrolled in representative cross-sectional questionnaire surveys in the Czech adult population in 2016 (n = 2,785) and 2018 (n = 1,665) were analysed. Prevalence rates were extrapolated to estimate numbers of current, i.e., last-year, users of psychedelics, and their socio-demographic profiles were compared with non-users and users of cannabis. RESULTS: An estimated 5-6% of the Czech adult population (350-430 thousand people) used classical psychedelics (LSD, psilocybin mushrooms, ayahuasca) in their lifetime, increasing up to 28-30% when cannabis is included (1.9-2.1 million users). Current use of classical psychedelics reached 0.7-1.9% (50-130 thousand people), and 9-11% (590-750 thousand users) when cannabis was included. Users of psychedelics were more often males, of younger age and single. CONCLUSIONS: No significant socio-demographic differences were found between users of classical psychedelics and recreational cannabis users, however, differences were significant when compared to non-users and users of other illicit drugs. Findings should further serve to inform drug policy and social and healthcare systems in respect to the use of psychedelics.
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a Cannabis $7 D002188
- 650 _2
- $a průřezové studie $7 D003430
- 650 12
- $a halucinogeny $x terapeutické užití $7 D006213
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a zakázané drogy $7 D013287
- 650 12
- $a ketamin $7 D007649
- 650 _2
- $a LSD $7 D008238
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a psilocybin $7 D011562
- 650 12
- $a poruchy spojené s užíváním psychoaktivních látek $x epidemiologie $7 D019966
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kočárová, Rita $u National Institute of Mental Health, Klecany, Czech Republic $u Faculty of Arts, Charles University, Prague, Czech Republic $u Beyond Psychedelics, Prague, Czech Republic $7 xx0256551
- 700 1_
- $a Kňažek, Filip $u National Institute of Mental Health, Klecany, Czech Republic $u Faculty of Pharmacy, Masaryk University, Brno, Czech Republic $7 _AN088117
- 700 1_
- $a Plevková, Michaela $u National Institute of Mental Health, Klecany, Czech Republic $7 xx0283381
- 700 1_
- $a Bláhová, Barbora $u National Institute of Mental Health, Klecany, Czech Republic $7 xx0321393
- 700 1_
- $a Valeš, Karel $u National Institute of Mental Health, Klecany, Czech Republic $7 xx0070865
- 700 1_
- $a Mravčík, Viktor $u National Institute of Mental Health, Klecany, Czech Republic $u Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Spolecnost Podane ruce, Brno, Czech Republic $7 xx0018423
- 773 0_
- $w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 30, č. 3 (2022), s. 144-153
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36239361 $y Pubmed
- 910 __
- $a ABA008 $b B 1829 $c 562 $y p $z 0
- 990 __
- $a 20221108 $b ABA008
- 991 __
- $a 20230314101940 $b ABA008
- 999 __
- $a ok $b bmc $g 1896146 $s 1178276
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 30 $c 3 $d 144-153 $e 20220930 $i 1210-7778 $m Central European Journal of Public Health $n Cent. Eur. J. Public Health $x MED00001083
- LZP __
- $b NLK198 $a Pubmed-20221108
